PBSCTPeripheral Blood Stem Cell Transplant
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The oncologist performed leukocyte-associated antigen tests in the patient and her father, and PBSCT was planned and scheduled.
In light of her imminent PBSCT, the patient did not have sufficient time to wait for the onset of the next menstrual cycle and the success of COS using conventional methods was unlikely.
Suzuya et al., "Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling," Bone Marrow Transplantation, vol.
Recently, unmanipulated PBSCT [56] and unmanipulated G-BM [57] have been accomplished in haplo-SCT settings with very encouraging results.
compared IR for one year after transplantation in 51 patients receiving HLA-matched PBSCT following nonmyeloablative conditioning with a reference group of 67 myeloablative recipients [60].
(3) Nonstandard abbreviations: NSM, nonsecretory myeloma; AL amyloidosis, primary amyloidosis; FLC, free light chain; BJP, Bence Jones protein; PBSCT, peripheral blood stem cell transplantation; KFLC, [kappa] free light chain; LFLC, [lambda] free light chain; K/L FLC ratio, [kappa]/[lambda] free light chain ratio; M-protein, monoclonal protein; MM, multiple myeloma; and MGUS, monoclonal gammopathy of undetermined significance.
In a retrospective, single-center study, patients with first chronic phase chronic myeloid leukemia (CML) who underwent peripheral blood stem cell transplantation (PBSCT) fared better than those treated with bone marrow transplantation (BMT) from HLA-compatible unrelated donors.
Transplant related mortality was 5% among 37 PBSCT recipients (median follow-up 17 months) compared with 31% in the 54 BMT recipients (median follow-up 29 months), according to researchers from University Hospital of Essen, Germany.
McQuellon and colleagues (1976) have recently reported that long-term quality of life in breast cancer patients is unchanged following HDC/ PBSCT. These authors also reported that in structured interviews, concerns about physical appearance and about personal and physical relations emerged.
Corresponding figures in the HDC/ PBSCT group were 42.7 [+ or -] 9.8 months (range 7-181).
Methods: We performed a retrospective analysis of the outcomes in relapsed/refractory AML patients who underwent PBSCT from HRDs (n = 36).
Methods: Totally, 345 consecutive patients undergoing first HLA-matched sibling peripheral blood stem cell transplantation (PBSCT) from February 2004 to June 2013 at Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, were enrolled in this study.